Remedee Labs
PrivateLast Round
Series B
Dec 6, 2022
Total Funding Raised
$23.81M
Company Overview
Remedee Labs operates in Healthcare & Life Sciences and is based in Meylan. Its latest recorded funding round was a Series B round in December 2022.
Remedee Labs is a healthtech company that develops non-pharmacological neuromodulation technology for chronic pain management, including an endorphin-stimulating wristband.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Patient Engagement
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedee Labs Comparables
Compare Remedee Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| electroCore | 75% | |
| Sana Health | 73% | |
| Cefaly Technology | 67% |
For institutional investors. Book with your work email.
Remedee Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 6, 2022 | ||||
| Series A | Apr 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Remedee Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Partech | Series A |
| Banque Populaire | Series B |
| Supernova Invest | Series A |
| HCVC | Series B, Series A |
| Bpifrance | Series B |
| C4 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors grew 41% MoM.
- Jan 1, 2026
Monthly visitors increased 55% MoM.
For institutional investors. Book with your work email.
Remedee Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Remedee Labs's valuation, stock price, and market status.
Is Remedee Labs a public or private company?
Remedee Labs is a private company.
What is the current stock price of Remedee Labs?
Remedee Labs is a private company, so its shares have no public market price. Caplight tracks Remedee Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remedee Labs worth (valuation)?
Valuation information for Remedee Labs is not publicly available.
Can I buy Remedee Labs stock?
Remedee Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remedee Labs's last funding round?
Remedee Labs's most recent funding round was Series B on December 6, 2022.
Who are the main investors in Remedee Labs?
Key investors in Remedee Labs include HCVC.
Will Remedee Labs IPO soon?
No public IPO plans have been announced for Remedee Labs.
How can I track Remedee Labs secondary market activity?
Caplight tracks bids, offers, and trades in Remedee Labs's shares on secondary markets.